Cargando…
Riluzole: A neuroprotective drug with potential as a novel anti-cancer agent (Review)
Riluzole, a glutamate release inhibitor, has been in use for the treatment of amyotrophic lateral sclerosis for over two decades since its approval by the Food and Drug Administration. Recently, riluzole has been evaluated in cancer cells and indicated to block cell proliferation and/or induce cell...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562386/ https://www.ncbi.nlm.nih.gov/pubmed/34713302 http://dx.doi.org/10.3892/ijo.2021.5275 |